14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.91 $2.54 Thursday, 2nd May 2024 CANF stock ended at $2.03. This is 2.87% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 9.44% from a day low at $2.01 to a day high of $2.20.
90 days $1.91 $2.71
52 weeks $1.81 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Dec 07, 2023 $2.35 $2.38 $2.22 $2.22 18 811
Dec 06, 2023 $2.27 $2.42 $2.06 $2.31 70 436
Dec 05, 2023 $2.20 $2.40 $2.20 $2.25 73 725
Dec 04, 2023 $2.44 $2.44 $2.27 $2.32 41 421
Dec 01, 2023 $2.31 $2.46 $2.31 $2.44 42 093
Nov 30, 2023 $2.23 $2.42 $2.23 $2.35 75 590
Nov 29, 2023 $2.30 $2.37 $2.26 $2.32 40 587
Nov 28, 2023 $2.33 $2.44 $2.24 $2.34 57 848
Nov 27, 2023 $2.14 $2.39 $2.07 $2.38 170 356
Nov 24, 2023 $2.10 $2.11 $1.98 $2.04 42 195
Nov 22, 2023 $2.16 $2.16 $1.99 $2.11 176 390
Nov 21, 2023 $2.16 $2.80 $1.83 $2.14 4 441 661
Nov 20, 2023 $1.98 $2.01 $1.98 $2.01 1 103
Nov 17, 2023 $1.98 $1.98 $1.94 $1.98 2 985
Nov 16, 2023 $2.01 $2.09 $1.92 $1.92 6 244
Nov 15, 2023 $1.93 $2.00 $1.93 $2.00 14 729
Nov 14, 2023 $1.98 $1.98 $1.91 $1.92 5 219
Nov 13, 2023 $1.85 $2.06 $1.85 $1.91 5 563
Nov 10, 2023 $2.00 $2.00 $1.92 $1.94 5 170
Nov 09, 2023 $2.11 $2.14 $2.01 $2.01 6 983
Nov 08, 2023 $2.16 $2.16 $2.10 $2.16 3 853
Nov 07, 2023 $2.13 $2.15 $2.13 $2.15 3 118
Nov 06, 2023 $2.14 $2.18 $2.14 $2.16 3 501
Nov 03, 2023 $2.17 $2.19 $2.16 $2.18 11 264
Nov 02, 2023 $2.13 $2.17 $2.13 $2.16 5 921
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT